Stocks and InvestingStocks and Investing
Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022

Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $19 on, May 13th, 2022


Published on 2024-10-27 21:04:31 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $20 to $19 on, May 13th, 2022.

Jonathan has made no other calls on VINC in the last 4 months.



There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $28 on, Wednesday, March 30th, 2022